Scientists at UdeM and its affiliated research institute IRIC have developed a new drug-discovery platform for high-risk leukemias in children – with promising results.
Scientists at UdeM and its affiliated research institute IRIC have developed a new drug-discovery platform for high-risk leukemias in children – with promising results.